Clinical Trial

Prognostic Value of TIL in Nasopharyngeal Carcinoma

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Our center plans to conduct a prospective, multicenter, observational study aimed at observing the percentage of TIL infiltration calculated using deep learning methods based on digital pathological images, and analyzing its prognostic significance in nasopharyngeal carcinoma, in order to help guide personalized treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-07.
Trial Details
NCT Number NCT06763640
Lead Sponsor Jiangxi Provincial Cancer Hospital
Conditions Nasopharyngeal Carcinoma (NPC)
Enrollment 216 participants
Start Date 2025-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-09